Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16765759 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W)
Conditions: Atrial Fibrillation;   Vascular Risk
Intervention: Drug: clopidogrel (SR25990C)

Indicates status has not been verified in more than two years